weight loss semaglutide ohio Program – Access Ohio calls out weight-loss drug

Even with insurance, approval for weight loss indications can be inconsistent, as many plans only cover it for diabetes treatment

Yes, in moderation

Given that the Wegovy injection received a restricted NICE recommendation in 2023, limiting NHS prescribing to specialist weight management services, oral semaglutide (the pill) is likely to follow a similar path

Serious adverse events were similar in incidence between the groups

An interim analysis was planned after two thirds of the total events had accrued with clear stopping rules and an alpha spending function to account for this interim look (in fact, the interim analysis did not take place until 741 events, out of the planned 854, took place)